☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

MeReC Extra 44

The National Prescribing Centre has published MeReC Extra 44 (PDF) which contains information regarding a recent Cochrane review of combination therapy in asthma and use of antipsychotic drugs in dementia.

Observational data indicate that the addition of long-acting beta-agonists (LABA) is frequently given to steroid naive patients with mild asthma. A review of randomised trials conducted by the Cochrane Collaboration compared LABA and inhaled corticosteroid (ICS) therapy was not associated with a reduction in exacerbations requiring oral steroid or resulting in hospital admission when compared to ICS alone. There were some differences in some measures of lung function, frequency of short-acting beta-agonist use and symptoms.

The authors of the Cochrane review conclude that there is "insufficient evidence to support initiating therapy with a combination of inhaled corticosteroids (ICS) and long-acting ß2-agonist (LABA) rather than with inhaled corticosteroids alone". These results therefore support the current British Thoracic Society step-wise approach to treating asthma.

This MeReC Extra also discusses the results of an independent report on prescribing of antipsychotics in people with dementia. This report identified evidence of over-prescribing of antipsychotic drugs and made recommendations to the government. These recommendations have been accepted and may result in policy change. In the meantime clinicians should consider using non-pharmacological approaches to dealing with anxiety and behavioural problems if these are locally available.

Action: Clinicians who see patients with asthma or dementia will find this information useful and informative.

Share 'MeReC Extra 44' by emailShare 'MeReC Extra 44' on FacebookShare 'MeReC Extra 44' on TwitterShare 'MeReC Extra 44' on LinkedInShare 'MeReC Extra 44' on reddit


No Comments to “MeReC Extra 44”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.